Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals

PLoS Pathogens

Volumn 4, Issue 7, 2008, Pages

  Fogli, Manuela ^a   Mavilio, Domenico ^a,b   Brunetta, Enrico ^a,b   Varchetta, Stefania ^a,b,c   Ata, Khaled ^a   Roby, Gregg ^a   Kovacs, Colin ^d   Follmann, Dean ^a   Pende, Daniela ^e   Ward, Jeffrey ^f   Barker, Edward ^g   Marcenaro, Emanuela ^h   Moretta, Alessandro ^h   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF GENOA   (Italy)

^f State University of New York Upstate Medical University: College of Medicine   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD16 ANTIGEN; CD56 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHYTOHEMAGGLUTININ; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 7; GAG PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; INTERLEUKIN 2; RECOMBINANT PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOBLAST; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; VIREMIA; VIRUS REPLICATION; BLOOD; CELL PROLIFERATION; CYTOTOXICITY; IMMUNOLOGY; METABOLISM; MONOCYTE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; HIV CORE PROTEIN P24; HIV INFECTIONS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; MONOCYTES, ACTIVATED KILLER; RECOMBINANT PROTEINS; VIRUS REPLICATION;

EID: 48249116797     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000101     Document Type: Article

References (37)

1. Cerwenka A, Lanier LL (2001) Natural killer cells, viruses and cancer. Nat Rev Immunol 1: 41-49.
2. Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640.
3. Karre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
4. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
5. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L (2002) What is a natural killer cell? Nat Immunol 3: 6-8.
6. De Maria A, Fogli M, Costa P, Murdaca G, Puppo F, et al. (2003) The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 33: 2410-2418.
7. Mavilio D, Benjamin J, Daucher M, Lombardo G, Kottilil S, et al. (2003) Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A 100: 15011-15016.
8. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, et al. (2006) Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 203: 2339-2350.
9. Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, et al. (2005) Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106: 3366-3369.
10. Hu PF, Hultin LE, Hultin P, Hausner MA, Hirji K, et al. (1995) Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol 10: 331-340.
11. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, et al. (2005) Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A.
12. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183-188.
13. Pierson T, McArthur J, Siliciano RF (2000) Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annual review of immunology 18: 665-708.
14. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
15. Bonaparte MI, Barker E (2004) Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 104: 2087-2094.
16. Noraz N, Verrier B, Fraisier C, Desgranges C (1995) Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses. AIDS research and human retroviruses 11: 145-154.
17. Ward J, Bonaparte M, Sacks J, Guterman J, Fogli M, et al. (2007) HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 110: 1207-1214.
18. Asjo B, Cefai D, Debre P, Dudoit Y, Autran B (1993) A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes. Journal of virology 67: 4395-4398.
19. Chun TW, Engel D, Mizell SB, Ehler LA, Fauci AS (1998) Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. The Journal of experimental medicine 188: 83-91.
20. Smithgall MD, Wong JG, Critchett KE, Haffar OK (1996) IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. Journal of immunology (Baltimore, Md 156: 2324-2330.
21. Wang FX, Xu Y, Sullivan J, Souder E, Argyris EG, et al. (2005) IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. The Journal of clinical investigation 115: 128-137.
22. Bahbouhi B, Landay A, Al-Harthi L (2004) Dynamics of cytokine expression in HIV productively infected primary CD4+ T cells. Blood 103: 4581-4587.
23. Zimmerman ES, Sherman MP, Blackett JL, Neidleman JA, Kreis C, et al. (2006) Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J Virol 80: 10407-10418.
24. Lundquist CA, Tobiume M, Zhou J, Unutmaz D, Aiken C (2002) Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. Journal of virology 76: 4625-4633.
25. Wildum S, Schindler M, Munch J, Kirchhoff F (2006) Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. Journal of virology 80: 8047-8059.
26. Scott-Algara D, Paul P (2002) NK cells and HIV infection: lessons from other viruses. Curr Mol Med 2: 757-768.
27. Fauci AS, Mavilio D, Kottilil S (2005) NK cells in HIV infection: Paradigm for protection or targets for ambush. Nat Rev Immunol 5: 835-843.
28. Alter G, Altfeld M (2006) NK cell function in HIV-1 infection. Curr Mol Med 6: 621-629.
29. Ward JP, Bonaparte MI, Barker E (2004) HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts. AIDS (London, England) 18: 1769-1779.
30. Nattermann J, Nischalke HD, Hofmeister V, Kupfer B, Ahlenstiel G, et al. (2005) HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antiviral therapy 10: 95-107.
31. Mela CM, Burton CT, Imami N, Nelson M, Steel A, et al. (2005) Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy. Aids 19: 1761-1769.
32. Cerboni C, Neri F, Casartelli N, Zingoni A, Cosman D, et al. (2007) Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 88: 242-250.
33. Alimonti JB, Ball TB, Fowke KR (2003) Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 84: 1649-1661.
34. Vieillard V, Strominger JL, Debre P (2005) NK cytotoxicity against CD4+ T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A 102: 10981-10986.
35. Vieillard V, Le Grand R, Dausset J, Debre P (2008) A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques. Proc Natl Acad Sci U S A 105: 2100-2104.
36. Setini A, Beretta A, De Santis C, Meneveri R, Martayan A, et al. (1996) Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin. Hum Immunol 46: 69-81.
37. Mavilio D, Benjamin J, Kim D, Lombardo G, Daucher M, et al. (2005) Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood 106: 1718-1725.